Grown Rogue International (GRUSF) Non-cash Items (2009 - 2025)
Grown Rogue International's (GRUSF) quarterly Non-cash Items came in at $2361.9 billion in Q3 2025, down 41.99% year-on-year from $4071.4 billion in Q3 2024, and up 14933623761.58% quarter-over-quarter from $15816.0 in Q2 2025.
Grown Rogue International (GRUSF) Non-cash Items (2009 - 2025) Analysis & Trends
Grown Rogue International's Non-cash Items history runs 14 years deep, the most recent figure standing at $2361.9 billion for Q3 2025.
- On a quarterly basis, Non-cash Items fell 41.99% year-over-year to $2361.9 billion in Q3 2025; TTM through Sep 2025 was -$1709.4 billion, a 141.99% decrease from a year earlier, with the FY2024 full-year figure at $5.7 million, up 669.86% from the prior year.
- Non-cash Items rose to $2361.9 billion in Q3 2025 per GRUSF's latest filing, from $15816.0 in the prior quarter.
- Across five years, Non-cash Items topped out at $4071.4 billion in Q3 2024 and bottomed at -$4071.4 billion in Q4 2024.
- The 5-year median for Non-cash Items is $1.1 million (2024), against an average of $147.6 billion.
- Across the five-year window, Non-cash Items sank 140.59% in 2021 and soared 248.64% in 2022, its largest moves.
- Year by year, Non-cash Items stood at $948813.0 in 2021, then tumbled by 50.92% to $465720.0 in 2022, then jumped by 999.69% to $5.1 million in 2023, then sank by 79495626.68% to -$4071.4 billion in 2024, then soared by 158.01% to $2361.9 billion in 2025.
- Per Business Quant, the three latest GRUSF Non-cash Items figures stand at $2361.9 billion (Q3 2025), $15816.0 (Q2 2025), and $1.0 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2,361.90 Bn |
| Sep 30, 2025 | 2,361.90 Bn |
| Jun 30, 2025 | 15,816.00 |
| Jun 30, 2025 | 15,816.00 |
| Mar 31, 2025 | 1.03 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | -4,071.35 Bn |
| Dec 31, 2024 | -4,071.35 Bn |
| Sep 30, 2024 | 4,071.36 Bn |
| Sep 30, 2024 | 4,071.36 Bn |
| Jun 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 1.15 Mn |
| Mar 31, 2024 | 1.76 Mn |
| Mar 31, 2024 | 1.76 Mn |
| Oct 31, 2023 | 5.12 Mn |
| Oct 31, 2023 | 5.12 Mn |
| Jul 31, 2023 | 3.60 Mn |
| Jul 31, 2023 | 3.60 Mn |
| Apr 30, 2023 | 1.75 Mn |
| Apr 30, 2023 | 1.75 Mn |